Hambach, Germany

Karen Reimer

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 187(Granted Patents)


Location History:

  • Hambach, DE (2007 - 2013)
  • Limburg, DE (1999 - 2018)

Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karen Reimer

Introduction

Karen Reimer is a notable inventor based in Hambach, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in pain management and respiratory diseases. With a total of 7 patents to her name, her work has the potential to impact many patients suffering from chronic conditions.

Latest Patents

Among her latest patents is a groundbreaking combination of oxycodone and naloxone. This invention is designed for use in treating pain in patients who are also suffering from diseases that result in intestinal dysbiosis or increase the risk of intestinal bacterial translocation. Another significant patent involves an opioid controlled release oral dosage form aimed at treating patients with Chronic Obstructive Pulmonary Disease (COPD). These innovations highlight her commitment to improving patient care through effective medication.

Career Highlights

Throughout her career, Karen has worked with reputable companies such as Euro-Celtique S.A. and Purdue Pharma L.P. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in pharmaceutical treatments.

Collaborations

Karen has collaborated with esteemed colleagues, including Wolfgang Fleischer and Petra Leyendecker. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Karen Reimer's contributions to the field of pharmaceuticals are noteworthy and impactful. Her innovative patents and collaborations demonstrate her dedication to improving healthcare solutions for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…